Genital Neoplasms clinical trials at UCLA

1 research study open to eligible people

Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
open to eligible people ages 18 years and up
The purpose of this study is to characterize the safety and tolerability of ALTA2618 in adults with AKT1 E17K-mutant advanced solid tumors.
Los Angeles, California and other locations

Last updated: November 25, 2025